Mirago 25 mg contains the active ingredient Mirabegron, primarily used to treat overactive bladder symptoms. It helps relieve painful or frequent urination and reduces the urgency to urinate that may accompany urinary tract infections. An overactive bladder is a condition in which urinary bladder muscles constrict uncontrollably, resulting in an urgent need to urinate, frequent urination, and inability to control urination. Mirabegron causes the urinary bladder muscles to relax, which, in turn, reduces the activity of the overactive bladder. It does this by stopping the sudden contraction of urinary bladder muscles, which allows control over urination.

Mirago 25 mg is advised to be taken as prescribed. It is a tablet that can be taken before or after consuming food. Do not chew or crush the pill. You should not stop taking this medicine without your doctor's approval. Sudden discontinuation may lead to worsening of your symptoms. Complete the full course of treatment for better effectiveness of the medicine.

Do not take Mirago if you have a history of hypersensitivity to Mirabegron or its inactive ingredients. Before receiving Mirago 25 mg, inform your doctor if you are suffering from any other condition or are taking other medications. Women should also inform their healthcare provider of their pregnancy (if they are trying to conceive or have already conceived). Patients suffering from liver or kidney disease must be cautious and follow the expert's advice while receiving this medicine.

Some common side effects of Mirabegron are headaches, high blood pressure, constipation, rapid heartbeat, joint pain, and urinary tract infection. If these side effects trouble or persist, speak to your doctor immediately.